UPDATES AND COMMENTARIES

JAMA cover.jpg
Emergency Use Authorizations During the COVID-19 Pandemic Lessons From Hydroxychloroquine for Vaccine Authorization and Approval
JAMA, October 10, 2020
"Because COVID-19 vaccines are being developed at an unprecedented pace, and because their review will also occur during a pandemic and in a presidential election year, lessons from the hydroxychloroquine authorization may apply to the regulation of these vaccines...questions are being raised about the rigor and speed with which the FDA will assess the safety and efficacy of vaccines before granting marketing authorizations via EUAs or licensure"